US Regulation of Pharmaceutical Outcomes Research Presented at the ISPOR 5th Annual International Meeting, Crystal City, VA, 24 May 2000
The views expressed in this article are those of the author and do not represent the official opinion or policy of the Food and Drug Administration.
Address correspondence to: Laurie B. Burke, Chief, Evidence Review Branch, DDMAC, U. S. Food and Drug Administration, 5600 Fishers Lane, Mail Stop HFD-42, Rockville, MD 20857. E-mail: email@example.com
No abstract is available for this article.